Healthcare is the most critical element of an emerging economy. Working with leading players allows me to contribute in shaping the industry to achieve improved outcomes for the community.
Ujwal provides mergers and acquisitions (M&A) and growth equity advisory services to clients in the healthcare sector. He identifies private equity groups and high growth companies seeking growth capital targets for clients and manages communication with clients, investors and buyers.
Ujwal has led transaction execution for several companies in the healthcare sector, which include healthcare services, hospitals, out-of-hospital care, home care, pharma and medical devices.
Prior to joining Lincoln, Ujwal worked as an associate at a boutique advisory firm in Mumbai, where he focused on healthcare delivery transactions.
Ujwal earned a Master of Business Administration from Bombay University and a Bachelor of Engineering from Pune University.
Recent Transactions in India
Lincoln International represented India’s Eternis Fine Chemicals Limited in its acquisition of Tennants Fine Chemicals Limited (TFC), the UK’s largest primary manufacturer of specialty aroma chemicals
Lincoln International is pleased to announce that Investcorp has acquired Unilog
Lincoln International advised Kyokuto Kaihatsu Kogyo Co. Ltd. on its acquisition of Satrac Engineering Pvt. Ltd.
Lincoln International is pleased to announce that its client Miranda Tools has entered into an agreement to sell its high-speed steel cutting tools business to Dormer Pramet
Lincoln International is pleased to announce that LogiNext Solutions has raised growth capital from Steadview Capital and Tiger Global
Lincoln International is pleased to announce that the Greytip Software raised growth capital from Info Edge (India) Limited and MegaDelta Capital
Lincoln International advised on the sale of Nova IVI, India’s second largest provider of fertility treatment services, to TPG Growth